Cargando…
Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist
BACKGROUND: The Korean Academy of Medical Sciences (KAMS) has been utilizing AGREE II to audit the quality of clinical practice guidelines (CPGs) developed in Korea. Monitoring the RIGHT Checklist adherence could help monitor the quality status and discover areas for improvement of CPG development....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787803/ https://www.ncbi.nlm.nih.gov/pubmed/35075825 http://dx.doi.org/10.3346/jkms.2022.37.e26 |
_version_ | 1784639432090976256 |
---|---|
author | Choi, Miyoung Lee, You Kyoung Kim, Soo Young |
author_facet | Choi, Miyoung Lee, You Kyoung Kim, Soo Young |
author_sort | Choi, Miyoung |
collection | PubMed |
description | BACKGROUND: The Korean Academy of Medical Sciences (KAMS) has been utilizing AGREE II to audit the quality of clinical practice guidelines (CPGs) developed in Korea. Monitoring the RIGHT Checklist adherence could help monitor the quality status and discover areas for improvement of CPG development. METHODS: We included 129 CPGs from the past 5 years and assessed each item of the RIGHT Checklist. STATA version 15.0 was used for statistical analysis. RESULTS: Among the seven sections of the RIGHT checklist, sections with a full compliance rate over 60% were ‘basic information’ (65%) and ‘background’ (66%). The other sections’ mean full compliance rates were ‘Evidence’ 52%, ‘Recommendation’ 35%, ‘Review and quality assurance’ 25% and ‘Funding, declaration and management of interest’ 17%. Sections with a partial compliance rate over 60% were ‘Recommendation’ (60%) and ‘Funding, declaration and management of interest’ (70%). Non-compliance was highest in the ‘Review and quality assurance’ (17%) domain. In comparison between groups 1 (under median group) and 2 (over median group), group 2 showed a tendency to have multi-stakeholder involvement and present sufficient information on financial resources and conflict of interest declarations. For the CPGs developmental methodology aspect, group 2 provided more pertinent information than group 1 about supporting evidence-making and the process from evidence to recommendation. CONCLUSION: This study evaluated adherence to the RIGHT Checklist of CPGs developed in Korea. It can provide helpful information to develop strategic plans for enhancing the capabilities of developing CPGs in Korea. |
format | Online Article Text |
id | pubmed-8787803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Academy of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-87878032022-01-27 Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist Choi, Miyoung Lee, You Kyoung Kim, Soo Young J Korean Med Sci Original Article BACKGROUND: The Korean Academy of Medical Sciences (KAMS) has been utilizing AGREE II to audit the quality of clinical practice guidelines (CPGs) developed in Korea. Monitoring the RIGHT Checklist adherence could help monitor the quality status and discover areas for improvement of CPG development. METHODS: We included 129 CPGs from the past 5 years and assessed each item of the RIGHT Checklist. STATA version 15.0 was used for statistical analysis. RESULTS: Among the seven sections of the RIGHT checklist, sections with a full compliance rate over 60% were ‘basic information’ (65%) and ‘background’ (66%). The other sections’ mean full compliance rates were ‘Evidence’ 52%, ‘Recommendation’ 35%, ‘Review and quality assurance’ 25% and ‘Funding, declaration and management of interest’ 17%. Sections with a partial compliance rate over 60% were ‘Recommendation’ (60%) and ‘Funding, declaration and management of interest’ (70%). Non-compliance was highest in the ‘Review and quality assurance’ (17%) domain. In comparison between groups 1 (under median group) and 2 (over median group), group 2 showed a tendency to have multi-stakeholder involvement and present sufficient information on financial resources and conflict of interest declarations. For the CPGs developmental methodology aspect, group 2 provided more pertinent information than group 1 about supporting evidence-making and the process from evidence to recommendation. CONCLUSION: This study evaluated adherence to the RIGHT Checklist of CPGs developed in Korea. It can provide helpful information to develop strategic plans for enhancing the capabilities of developing CPGs in Korea. The Korean Academy of Medical Sciences 2022-01-06 /pmc/articles/PMC8787803/ /pubmed/35075825 http://dx.doi.org/10.3346/jkms.2022.37.e26 Text en © 2022 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Choi, Miyoung Lee, You Kyoung Kim, Soo Young Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist |
title | Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist |
title_full | Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist |
title_fullStr | Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist |
title_full_unstemmed | Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist |
title_short | Korean Clinical Practice Guidelines: Current Status of Adherence to the RIGHT Checklist |
title_sort | korean clinical practice guidelines: current status of adherence to the right checklist |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787803/ https://www.ncbi.nlm.nih.gov/pubmed/35075825 http://dx.doi.org/10.3346/jkms.2022.37.e26 |
work_keys_str_mv | AT choimiyoung koreanclinicalpracticeguidelinescurrentstatusofadherencetotherightchecklist AT leeyoukyoung koreanclinicalpracticeguidelinescurrentstatusofadherencetotherightchecklist AT kimsooyoung koreanclinicalpracticeguidelinescurrentstatusofadherencetotherightchecklist AT koreanclinicalpracticeguidelinescurrentstatusofadherencetotherightchecklist |